Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学In Vivo CRISPR, Hematopoietic Stem Cell Editing

Matthew Porteus

MD, PhD

🏢Stanford University School of Medicine🌐USA

Professor of Pediatrics

58
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Matthew Porteus is a leading researcher in using CRISPR gene editing for treating diseases of blood cells including leukemia and lymphoma. His laboratory has developed precision genome editing approaches in hematopoietic stem and progenitor cells with direct therapeutic applications for blood cancers and inherited hematopoietic disorders. He has contributed novel approaches to improving the safety and efficiency of in vivo CRISPR delivery and has been instrumental in translating these technologies toward clinical trials. He is a co-founder of CRISPR therapeutics company Graphite Bio.

Share:

🧪Research Fields 研究领域

CRISPR therapeutics
hematopoietic stem cells
in vivo delivery
blood cancers
gene correction

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Matthew Porteus 的研究动态

Follow Matthew Porteus's research updates

留下邮箱,当我们发布与 Matthew Porteus(Stanford University School of Medicine)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment